Update : Multistate outbreak of meningitis and stroke associated with potentially contaminated steroid medication

Details

• Alternative Title:
  Multistate outbreak of meningitis and stroke associated with potentially contaminated steroid medication
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration.
• Description:
  October 8, 2012, 13:10 ET (1:10 PM ET)
  
  CDCHAN-00328-2012-10-08-ADV-N
  
  The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to work closely with state public health departments on a multistate investigation of fungal meningitis among patients who received an epidural steroid injection. Some of these patients also suffered strokes that may have resulted from their infection. These cases are associated with a potentially contaminated steroid medication prepared by New England Compounding Center (NECC), located in Framingham, Mass. This HAN notice provides updated information about the investigation (including a change in the case definition), laboratory findings, an expanded voluntary recall of products, and recommendations for clinicians.
  
  
• Subjects:
  Anti-Inflammatory Agents/adverse Effects Aspergillus Fumigatus Disease Outbreaks Drug Compounding Drug Contamination Injections, Epidural Meningitis, Fungal Methylprednisolone Steroids/adverse Effects Stroke
• Source:
  HAN ; 328
• Series:
  Health Alert Network
• Document Type:
  HAN Health Advisory
• Place as Subject:
  United States
• Pages in Document:
  4 unnumbered pages
• Issue:
  328
• Collection(s):
  Health Alert Network (HAN)
• Main Document Checksum:
  urn:sha-512:031785034e5ac6443484d2c093d4127dd35ab0da88f0d365e35b217bee088d6fe7539838c35d353955791c8df35a21aef27bea9d98b83102e1724bf43b18fdb8
• Download URL:
  https://stacks.cdc.gov/view/cdc/25237/cdc_25237_DS1.pdf
• File Type:
  [PDF - 1.90 MB ]